Robins Kaplan LLP Announces a Class Action Settlement for Third Party-Payors that Made Payments or Provided Reimbursement for the Drug Daraprim from August 7, 2015 through January 28, 2022
Plaintiff has reached a proposed settlement that provides a minimum cash payment to the Settlement Class of $7 million and additional potential payments of up to $21 million for a total potential settlement amount of up to $28 million (the "Class Settlement Amount").
- Plaintiff has reached a proposed settlement that provides a minimum cash payment to the Settlement Class of $7 million and additional potential payments of up to $21 million for a total potential settlement amount of up to $28 million (the "Class Settlement Amount").
- If you are a member of the Settlement Class, your rights will be affected by the pending lawsuit and the Settlement, and you may be entitled to share in the Settlement Fund.
- A more detailed description of the Class Settlement Amount is available in the Settlement Agreement available for download at www.DaraprimTPPsettlement.com .
- If you are a Settlement Class Member, please review the full Notice, available at www.DaraprimTPPsettlement.com , concerning your rights and options.